Works by Mancuso, James P.

Results: 29

Long‐term weight loss and cardiorenal outcomes by baseline BMI in the VERTIS CV trial.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 583, doi. 10.1111/dom.16050

By:

Cosentino, Francesco;
Dagogo‐Jack, Samuel;
Frederich, Robert;
Cannon, Christopher P.;
Cherney, David Z. I.;
Mancuso, James P.;
Wynant, Willy;
Xing, Aiwen;
Gantz, Ira;
Cater, Nilo B.;
Pratley, Richard E.

Publication type:

Article

Effects of ertugliflozin on uric acid and gout‐related outcomes in persons with type 2 diabetes and cardiovascular disease: Post hoc analyses from VERTIS CV.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5336, doi. 10.1111/dom.15895

By:

Sridhar, Vikas S.;
Cosentino, Francesco;
Dagogo‐Jack, Samuel;
McGuire, Darren K.;
Pratley, Richard E.;
Cater, Nilo B.;
Noyes Essex, Margaret;
Mancuso, James P.;
Zhao, Yujie;
Cherney, David Z. I.

Publication type:

Article

Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1398, doi. 10.1111/dom.14965

By:

Kim, Joseph M.;
Bhatt, Deepak L.;
Dagogo‐Jack, Samuel;
Cherney, David Z. I.;
Cosentino, Francesco;
McGuire, Darren K.;
Pratley, Richard E.;
Liu, Chih‐Chin;
Cater, Nilo B.;
Frederich, Robert;
Mancuso, James P.;
Cannon, Christopher P.

Publication type:

Article

Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose‐lowering agent: An analysis from VERTIS CV.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1245, doi. 10.1111/dom.14691

By:

Dagogo‐Jack, Samuel;
Cannon, Christopher P.;
Cherney, David Z. I.;
Cosentino, Francesco;
Liu, Jie;
Pong, Annpey;
Gantz, Ira;
Frederich, Robert;
Mancuso, James P.;
Pratley, Richard E.

Publication type:

Article

Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trial.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 5, p. 1111, doi. 10.1111/dom.13194

By:

Pratley, Richard E.;
Eldor, Roy;
Raji, Annaswamy;
Golm, Gregory;
Huyck, Susan B.;
Sunga, Sheila;
Johnson, Jeremy;
Engel, Samuel S.;
Lauring, Brett;
Qiu, Yanping;
Terra, Steven G.;
Mancuso, James P.

Publication type:

Article

Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo‐controlled randomized study.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 530, doi. 10.1111/dom.13116

By:

Dagogo‐jack, Samuel;
Liu, Jie;
Eldor, Roy;
Amorin, Guillermo;
Johnson, Jeremy;
Hille, Darcy;
Liao, Yuqin;
Huyck, Susan;
Golm, Gregory;
Terra, Steven G.;
Mancuso, James P.;
Engel, Samuel S.;
Lauring, Brett

Publication type:

Article

Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial.

Published in:

European Heart Journal, 2023, v. 44, n. 48, p. 5163, doi. 10.1093/eurheartj/ehad639

By:

Pandey, Ambarish;
Kolkailah, Ahmed A;
Cosentino, Francesco;
Cannon, Christopher P;
Frederich, Robert C;
Cherney, David Z I;
Dagogo-Jack, Samuel;
Pratley, Richard E;
Cater, Nilo B;
Gantz, Ira;
Mancuso, James P;
McGuire, Darren K

Publication type:

Article

Increased Food Intake and Energy Expenditure Following Administration of Olanzapine to Healthy Men.

Published in:

Obesity (19307381), 2010, v. 18, n. 8, p. 1646, doi. 10.1038/oby.2010.6

By:

Fountaine, Robert J.;
Taylor, Ann E.;
Mancuso, James P.;
Greenway, Frank L.;
Byerley, Lauri O.;
Smith, Steven R.;
Most, Marlene M.;
Fryburg, David A.

Publication type:

Article

Efficacy and safety of ertugliflozin across racial groups in patients with type 2 diabetes mellitus.

Published in:

2020

By:

Liu, Jie;
Tarasenko, Lisa;
Pong, Annpey;
Huyck, Susan;
Wu, Larry;
Patel, Shrita;
Hickman, Anne;
Mancuso, James P.;
Gantz, Ira;
Terra, Steven G.

Publication type:

journal article

Efficacy and safety of ertugliflozin in Hispanic/Latino patients with type 2 diabetes mellitus.

Published in:

2020

By:

Liu, Jie;
Tarasenko, Lisa;
Pong, Annpey;
Huyck, Susan;
Patel, Shrita;
Hickman, Anne;
Mancuso, James P.;
Ellison, Misoo C.;
Gantz, Ira;
Terra, Steven G.

Publication type:

journal article

Results of VERTIS SU extension study: safety and efficacy of ertugliflozin treatment over 104 weeks compared to glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin.

Published in:

2019

By:

Hollander, Priscilla;
Hill, Julie;
Johnson, Jeremy;
Wei Jiang, Zhi;
Golm, Gregory;
Huyck, Susan;
Terra, Steven G.;
Mancuso, James P.;
Engel, Samuel S.;
Lauring, Brett;
Liu, Jie

Publication type:

journal article

Safety of Ertugliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Seven Phase 3 Randomized Controlled Trials.

Published in:

Diabetes Therapy, 2020, v. 11, n. 6, p. 1347, doi. 10.1007/s13300-020-00803-3

By:

Patel, Shrita;
Hickman, Anne;
Frederich, Robert;
Johnson, Susan;
Huyck, Susan;
Mancuso, James P.;
Gantz, Ira;
Terra, Steven G.

Publication type:

Article

Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized Study.

Published in:

Diabetes Therapy, 2018, v. 9, n. 1, p. 253, doi. 10.1007/s13300-017-0358-0

By:

Miller, Sam;
Krumins, Tania;
Zhou, Haojin;
Huyck, Susan;
Johnson, Jeremy;
Golm, Gregory;
Terra, Steven G.;
Mancuso, James P.;
Engel, Samuel S.;
Lauring, Brett

Publication type:

Article

Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study.

Published in:

Diabetes Therapy, 2018, v. 9, n. 1, p. 193, doi. 10.1007/s13300-017-0354-4

By:

Hollander, Priscilla;
Liu, Jie;
Hill, Julie;
Johnson, Jeremy;
Jiang, Zhi Wei;
Golm, Gregory;
Huyck, Susan;
Terra, Steven G.;
Mancuso, James P.;
Engel, Samuel S.;
Lauring, Brett

Publication type:

Article

Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study.

Published in:

Diabetes Therapy, 2018, v. 9, n. 1, p. 49, doi. 10.1007/s13300-017-0337-5

By:

Grunberger, George;
Camp, Sarah;
Johnson, Jeremy;
Huyck, Susan;
Terra, Steven G.;
Mancuso, James P.;
Jiang, Zhi Wei;
Golm, Gregory;
Engel, Samuel S.;
Lauring, Brett

Publication type:

Article

Do Methodological Flaws Invalidate a Randomized Trial of Lifestyle Modification Programs in Obese Patients?

Published in:

2009

By:

Berger, Vance W.;
Mancuso, James P.;
Gerber, Robert A.;
Digenio, Andres G.

Publication type:

Letter

Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trial.

Published in:

2009

By:

Digenio AG;
Mancuso JP;
Gerber RA;
Dvorak RV;
Digenio, Andres G;
Mancuso, James P;
Gerber, Robert A;
Dvorak, Roman V

Publication type:

journal article

Comparison of Methods for Delivering a Lifestyle Modification Program for Obese Patients.

Published in:

Annals of Internal Medicine, 2009, v. 150, n. 4, p. 255, doi. 10.7326/0003-4819-150-4-200902170-00006

By:

Digenio, Andres G.;
Mancuso, James P.;
Gerber, Robert A.;
Dvorak, Roman V.

Publication type:

Article

Effects of ertugliflozin on renal function over 104 weeks of treatment: a post hoc analysis of two randomised controlled trials.

Published in:

Diabetologia, 2020, v. 63, n. 6, p. 1128, doi. 10.1007/s00125-020-05133-4

By:

Cherney, David Z. I.;
Heerspink, Hiddo J. L.;
Frederich, Robert;
Maldonado, Mario;
Liu, Jie;
Pong, Annpey;
Xu, Zhi J.;
Patel, Shrita;
Hickman, Anne;
Mancuso, James P.;
Gantz, Ira;
Terra, Steven G.

Publication type:

Article

Ertugliflozin and incident obstructive sleep apnea: an analysis from the VERTIS CV trial.

Published in:

Sleep & Breathing, 2023, v. 27, n. 2, p. 669, doi. 10.1007/s11325-022-02594-2

By:

Wojeck, Brian S.;
Inzucchi, Silvio E.;
Neeland, Ian J.;
Mancuso, James P.;
Frederich, Robert;
Masiukiewicz, Urszula;
Cater, Nilo B.;
McGuire, Darren K.;
Cannon, Christopher P.;
Yaggi, Henry Klar

Publication type:

Article

Efficacy of ertugliflozin in monotherapy or combination therapy in patients with type 2 diabetes: A pooled analysis of placebo-controlled studies.

Published in:

Diabetes & Vascular Disease Research, 2019, v. 16, n. 5, p. 415, doi. 10.1177/1479164119842513

By:

Liu, Jie;
Tarasenko, Lisa;
Terra, Steven G;
Huyck, Susan;
Wu, Larry;
Pong, Annpey;
Calle, Roberto A;
Gallo, Silvina;
Darekar, Amanda;
Mancuso, James P

Publication type:

Article

Age-Adjusted Exact Trend Tests in the Event of Rare Occurrences.

Published in:

Biometrics, 2002, v. 58, n. 2, p. 403, doi. 10.1111/j.0006-341X.2002.00403.x

By:

Mancuso, Jessica Y.;
Ahn, Hongshik;
Chen, James J.;
Mancuso, James P.

Publication type:

Article

Heart failure outcomes captured by adverse event reporting in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial.

Published in:

European Journal of Heart Failure, 2025, v. 27, n. 3, p. 521, doi. 10.1002/ejhf.3511

By:

Pandey, Ambarish;
Kolkailah, Ahmed A.;
McGuire, Darren K.;
Frederich, Robert C.;
Cater, Nilo B.;
Cosentino, Francesco;
Pratley, Richard E.;
Dagogo‐Jack, Samuel;
Cherney, David Z.I.;
Wynant, Willy;
Gantz, Ira;
Mancuso, James P.;
Masiukiewicz, Urszula;
Cannon, Christopher P.

Publication type:

Article

796-P: Cardiorenal Outcomes with Ertugliflozin by Baseline Cardiorenal Medications: An Analysis from VERTIS CV.

Published in:

Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-796-P

By:

CHERNEY, DAVID;
COSENTINO, FRANCESCO;
MCGUIRE, DARREN K.;
CHARBONNEL, BERNARD;
DAGOGO-JACK, SAMUEL;
PRATLEY, RICHARD E.;
SHIH, WEICHUNG J.;
MALDONADO, MARIO;
PONG, ANNPEY;
GANTZ, IRA;
FREDERICH, ROBERT;
MANCUSO, JAMES P.;
MASIUKIEWICZ, URSZULA;
CANNON, CHRISTOPHER P.

Publication type:

Article

786-P: Glycemic Efficacy and Safety of Ertugliflozin (ERTU) in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease Stage 3 (CKD 3): An Analysis from VERTIS CV.

Published in:

Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-786-P

By:

DAGOGO-JACK, SAMUEL;
PRATLEY, RICHARD E.;
CHERNEY, DAVID;
CHARBONNEL, BERNARD;
MCGUIRE, DARREN K.;
COSENTINO, FRANCESCO;
SHIH, WEICHUNG J.;
LIU, JIE;
FREDERICH, ROBERT;
MANCUSO, JAMES P.;
RAJI, ANNASWAMY;
GANTZ, IRA

Publication type:

Article

783-P: Cardiorenal Outcomes with Ertugliflozin by Baseline (BL) Glucose-Lowering Agent (GLA): An Analysis from VERTIS CV.

Published in:

Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-783-P

By:

CHARBONNEL, BERNARD;
DAGOGO-JACK, SAMUEL;
CANNON, CHRISTOPHER P.;
CHERNEY, DAVID;
COSENTINO, FRANCESCO;
MCGUIRE, DARREN K.;
SHIH, WEICHUNG J.;
LIU, JIE;
PONG, ANNPEY;
GANTZ, IRA;
FREDERICH, ROBERT;
MANCUSO, JAMES P.;
PRATLEY, RICHARD E.

Publication type:

Article

1197-P: Two-Year Effects of Ertugliflozin on Renal Function.

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1197-P

By:

CHERNEY, DAVID;
HEERSPINK, HIDDO L.;
FREDERICH, ROBERT;
MALDONADO, MARIO;
PONG, ANNPEY;
XU, ZHI JIN;
LIU, JIE;
MANCUSO, JAMES P.;
GANTZ, IRA;
TERRA, STEVEN G.

Publication type:

Article

2353-PUB: Efficacy and Safety of Ertugliflozin in Hispanic/Latino Patients (Pts) with Type 2 Diabetes Mellitus (T2DM).

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2353-PUB

By:

LIU, JIE;
TARASENKO, LISA;
ELLISON, MISOO C.;
PONG, ANNPEY;
HUYCK, SUSAN;
MANCUSO, JAMES P.;
TERRA, STEVEN G.;
GANTZ, IRA

Publication type:

Article

Comprehensive implementations of multiple imputation using retrieved dropouts for continuous endpoints.

Published in:

BMC Medical Research Methodology, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12874-025-02494-5

By:

Wang, Shuai;
Schwartz, Pamela F.;
Mancuso, James P.

Publication type:

Article